No retraction, correction or concern found when last checked on Oct 23, 2026.

Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease

Julie E. Horowitz, Jack A. Kosmicki, Amy Damask and 97 more

Nature Genetics · 2022 · CC BY

doi:10.1101/2020.12.14.20248176

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enters human host cells via angiotensin-converting enzyme 2 (ACE2) and causes coronavirus disease 2019 (COVID-19). Here, through a genome-wide association study, we identify a variant (rs190509934, minor allele frequency 0.2–2%) that downregulates ACE2 expression by 37% ( P = 2.7 × 10 − 8 ) and reduces the risk of SARS-CoV-2 infection by 40% (odds ratio = 0.60, P = 4.5 × 10 − 13 ), providing human genetic evidence that ACE2 expression levels influence COVID-19 risk. We also replicate the associations of six previously reported risk variants, of which four were further associated with worse outcomes in individuals infected with the virus (in/near LZTFL1 , MHC, DPP9 and IFNAR2 ). Lastly, we show that common variants define a risk score that is strongly associated with severe disease among cases and modestly improves the prediction of disease severity relative to demographic and clinical factors alone.

Full text

Its licence does not allow us to show the full text. Read it at PubMed Central:

References 39

1.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1056/nejmoa2001017
2.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1056/nejmoa2002032
3.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1016/s0140-6736(20)30566-3
4.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1016/s0140-6736(20)31189-2
5.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1001/jama.2020.26443
6.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
7.
A pneumonia outbreak associated with a new coronavirus of probable bat origin · 2020
No notice
8.
How many genetic variants remain to be discovered? · 2009
Not checked
9.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1126/science.aaz1776
10.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1016/j.cardiores.2006.09.006
11.
Exome sequencing and characterization of 49,960 individuals in the UK Biobank · 2020
No notice
12.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1016/j.omtm.2020.05.013
13.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1001/jama.2020.8707
14.
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients · 2020
No notice
15.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1001/jama.2020.13719
16.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1126/science.abd4570
17.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1016/j.yexcr.2014.05.008
18.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1186/s12864-018-4810-y
19.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1093/hmg/ddt266
20.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1007/s00726-014-1889-6
21.
SENP7 Potentiates cGAS Activation by Relieving SUMO-Mediated Inhibition of Cytosolic DNA Sensing · 2017
No notice
22.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.4049/jimmunol.164.6.3169
23.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1007/s00251-005-0057-2
24.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1126/science.1232685
25.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1073/pnas.1312237110
26.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1038/ajg.2011.112
27.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1073/pnas.0602800103
28.
Identifying gene targets for brain-related traits using transcriptomic and methylomic data from blood · 2018
No notice
29.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
30.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1126/science.aaf6814
31.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1038/s41436-019-0625-8
32.
The UK Biobank resource with deep phenotyping and genomic data · 2018
No notice
33.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1038/s41588-021-00870-7
34.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1038/ng.3985
35.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1038/ng.3795
36.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1038/ng.2653
37.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1093/bioinformatics/bts635
38.
A scaling normalization method for differential expression analysis of RNA-seq data · 2010
No notice
39.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1016/j.ajhg.2015.09.001

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.